greeksoup/ stock research

Rxo (RXO) Q2 FY2026 earnings: revenue $1.8 billion, up 25.0% on the year

Rxo, Inc. (RXO) reported revenue of $1.8 billion for Q2 FY2026, the quarter ended 30 June 2026, up 25.0% on the same quarter a year earlier. Net income was -$9 million, and diluted earnings per share $-0.05. The figures are the company's own, from the 10-Q it filed with the SEC on 6 August 2026.

Revenue$1.8 billionup 25.0%
Net income-$9 million
Diluted EPS$-0.05
QuarterQ2 FY2026ended 30 June 2026

The quarter, against the one before and a year earlier

LineQ2 FY2026Q1 FY2026Q2 FY2025Change on the year
Revenue1,7741,4251,419+25.0%
Cost of revenue1,4721,1711,118+31.7%
Gross profit302254301+0.3%
Gross margin17.0%17.8%21.2%
Selling, general and administrative211197214-1.4%
Operating income1.0-28.00.0n/a
Operating margin0.1%-2.0%0.0%
Pre-tax income-8.0-49.0-10.0n/a
Income tax1.0-13.0-1.0n/a
Net income-9.0-36.0-9.0n/a
Net margin-0.5%-2.5%-0.6%
Diluted EPS-$0.05-$0.21-$0.05n/a
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ2 FY2026Q1 FY2026Q2 FY2025Change on the year
Operating cash flow-40.0-7.023.0n/a
Capital expenditure12.017.014.0-14.3%
Free cash flow-52.0-24.09.0n/a
Free cash flow margin-2.9%-1.7%0.6%
Cash from investing-12.0-17.0-18.0n/a
Cash from financing46.028.0-3.0n/a
Depreciation and amortisation26.026.030.0-13.3%
Share-based compensation7.07.07.0+0.0%
Diluted shares, weighted170m169m169m+0.7%
Shares outstanding at period end165m165m164m+0.6%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ2 FY2026Q1 FY2026Q2 FY2025Change on the year
Shareholders' equity1,5061,5091,588-5.2%
Debt459430387+18.6%
Operating lease liabilities167182201-16.9%
Other liabilities1,3271,1471,025+29.5%
Total liabilities and equity3,4593,2683,201+8.1%
Goodwill1,1111,1111,125-1.2%
Intangible assets432442474-8.9%
Cash and equivalents15.021.018.0-16.7%
Receivables1,4441,2161,065+35.6%
Other assets457478519-11.9%
Total assets3,4593,2683,201+8.1%

Questions

What was Rxo's revenue in Q2 FY2026?

Rxo (RXO) reported revenue of $1.8 billion for Q2 FY2026, the quarter ended 30 June 2026, up 25.0% on the same quarter a year earlier.

How much did Rxo earn in Q2 FY2026?

Net loss for Q2 FY2026 was $9 million, and the diluted loss per share $0.05.

When did Rxo report Q2 FY2026 results?

Rxo filed its 10-Q for the quarter ended 30 June 2026 with the SEC on 6 August 2026.

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue9769789139301,0401,6671,4331,4191,4211,4691,4251,774
Cost of revenue7427436997008091,3571,1531,1181,1371,2031,1711,472
Gross profit234235214230231310280301284266254302
Gross margin24%24%23%25%22%19%20%21%20%18%18%17%
SG&A148146145154149218210214208200197211
Operating income6.014.0-12.00.0-20.0-24.0-30.00.0-7.0-42.0-28.01.0
Operating margin1%1%-1%0%-2%-1%-2%0%-0%-3%-2%0%
Pre-tax income-3.04.0-21.0-8.0-242-33.0-39.0-10.0-15.0-51.0-49.0-8.0
Tax raten/a50%n/an/an/an/an/an/an/an/an/an/a
Net income-1.02.0-15.0-7.0-243-25.0-31.0-9.0-14.0-46.0-36.0-9.0
Net margin-0%0%-2%-1%-23%-1%-2%-1%-1%-3%-3%-1%
Diluted EPS-$0.01$0.02-$0.13-$0.06-$1.81n/a-$0.18-$0.05-$0.08-$0.27-$0.21-$0.05
Operating cash flow4.019.07.0-5.0-7.0-7.0-2.023.023.07.0-7.0-40.0
Capital expenditure18.018.011.011.011.012.015.014.014.016.017.012.0
Free cash flow-14.01.0-4.0-16.0-18.0-19.0-17.09.09.0-9.0-24.0-52.0
Buybacks0.0n/an/an/a0.0n/an/an/an/an/an/an/a
Shares outstanding117m117m118m118m161m163m164m164m164m164m165m165m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 30 June 2026, filed 6 August 2026, accession 0001929561-26-000036: the filing on EDGAR. All of Rxo, Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install